Home

Par Drugs & Chemicals Ltd EPS

Image

Par Drugs & Chemicals Ltd

NSE: PAR

EPS

₹ 12.54

Last updated on: May 02, 2025

Key Highlights

  • The Earning per Share of Par Drugs & Chemicals Ltd is ₹ 12.54 as of 02 May 25 .
  • The earning per share of Par Drugs & Chemicals Ltd changed from ₹ 2.01 to ₹ 0.47 over 7 quarters. This represents a CAGR of -56.41% .

Historical Earning per Share of Par Drugs & Chemicals Ltd

No data available

* All values are in

Company Fundamentals for Par Drugs & Chemicals Ltd

Market Price of Par Drugs & Chemicals Ltd

1M

1Y

3Y

5Y

Monitoring Par Drugs & Chemicals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 May 2025103.99
30 Apr 202599.41
29 Apr 2025102.14
28 Apr 2025103.16
25 Apr 2025102.47
24 Apr 2025106.47
23 Apr 2025107.42
22 Apr 2025105.71
21 Apr 2025103.71
17 Apr 2025100.08

SWOT Analysis Of Par Drugs & Chemicals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Par Drugs & Chemicals Ltd

Asset Value vs Market Value of Par Drugs & Chemicals Ltd

Market Value

128

Asset Value

Value addition

1.1 X

60

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Par Drugs & Chemicals Ltd127.96
Sun Pharmaceutical Industries Ltd438778
Divis Laboratories Ltd161949
Cipla Ltd123222
Torrent Pharmaceuticals Ltd110200
Dr Reddys Laboratories Ltd98708

Historical Market Cap of Par Drugs & Chemicals Ltd

No data available

* All values are in crore

Historical Revenue of Par Drugs & Chemicals Ltd

No data available

* All values are in crore

Historical EBITDA of Par Drugs & Chemicals Ltd

No data available

* All values are in crore

Historical Net Profit of Par Drugs & Chemicals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Par Drugs & Chemicals Ltd News Hub

Par Drugs & Chemicals AGM scheduled

Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be he

Read more

19 Aug 24

Par Drugs & Chemicals to declare Quarterly Result

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024

Read more

10 Aug 24

Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter

Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as ag

Read more

05 Aug 24

Par Drugs & Chemicals to declare Quarterly Result

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 22 October 202

Read more

14 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Par Drugs & Chemicals Ltd

What is the EPS of Par Drugs & Chemicals Ltd stock?

The Earnings Per Share (EPS) of Par Drugs & Chemicals Ltd is 12.54. An EPS is the amount of net income attributed to each share of a common stock.

How is Par Drugs & Chemicals Ltd EPS calculated?

The EPS of Par Drugs & Chemicals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Par Drugs & Chemicals Ltd report its EPS?

Par Drugs & Chemicals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Par Drugs & Chemicals Ltd EPS?

Factors that influence the EPS of Par Drugs & Chemicals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Par Drugs & Chemicals Ltd EPS growth indicate future performance?

Yes, consistent growth in Par Drugs & Chemicals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions